Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gentrification drives patterns of alpha and beta diversity in cities.
Fidino M, Sander HA, Lewis JS, Lehrer EW, Rivera K, Murray MH, Adams HC, Kase A, Flores A, Stankowich T, Schell CJ, Salsbury CM, Rohnke AT, Jordan MJ, Green AM, R Gramza A, Zellmer AJ, Williamson J, Surasinghe TD, Storm H, Sparks KL, Ryan TJ, Remine KR, Pendergast ME, Mullen K, Minier DE, Middaugh CR, Mertl AL, McClung MR, Long RA, Larson RN, Kohl MT, Harris LR, Hall CT, Haight JD, Drake D, Davidge AM, Cheek AO, Bloch CP, Biro EG, Anthonysamy WJB, Angstmann JL, Allen ML, Adalsteinsson SA, Short Gianotti AG, LaMontagne JM, Gelmi-Candusso TA, Magle SB. Fidino M, et al. Among authors: kase a. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2318596121. doi: 10.1073/pnas.2318596121. Epub 2024 Apr 15. Proc Natl Acad Sci U S A. 2024. PMID: 38621142
Patient-derived tumor xenograft study with CDK4/6 inhibitor plus AKT inhibitor for the management of metastatic castration-resistant prostate cancer.
Kase AM, Gleba J, Miller JL, Miller E, Petit J, Barrett MT, Zhou Y, Parent EE, Cai H, Knight JA, Orme J, Reynolds J, Durham WF, Metz TM, Meurice N, Edenfield B, Alasonyalilar Demirer A, Bilgili A, Hickman PG, Pawlush ML, Marlow L, Wickland DP, Tan W, Copland JA. Kase AM, et al. Mol Cancer Ther. 2024 Mar 6. doi: 10.1158/1535-7163.MCT-23-0296. Online ahead of print. Mol Cancer Ther. 2024. PMID: 38442920
A real-world experience of pembrolizumab monotherapy in microsatellite instability-high and/or tumor mutation burden-high metastatic castration-resistant prostate cancer: outcome analysis.
Mosalem O, Tan W, Bryce AH, Dronca RS, Childs DS, Pagliaro LC, Orme JJ, Kase AM. Mosalem O, et al. Among authors: kase am. Prostate Cancer Prostatic Dis. 2024 Feb 10. doi: 10.1038/s41391-024-00799-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2024. PMID: 38341460
The Bivalent Bromodomain Inhibitor MT-1 Inhibits Prostate Cancer Growth.
Shukla S, Riveros C, Al-Toubat M, Chardon-Robles J, Osumi T, Serrano S, Kase AM, Petit JL, Meurice N, Gleba J, Copland JA 3rd, Chauhan J, Fletcher S, Balaji KC. Shukla S, et al. Among authors: kase am. Cancers (Basel). 2023 Jul 28;15(15):3851. doi: 10.3390/cancers15153851. Cancers (Basel). 2023. PMID: 37568667 Free PMC article.
Closing the Gap in Direct Admissions: A Quality Improvement Project.
McKenna AL, Carter LE, Kase AM, McCain JD, Fitzgerald PJ, Kesler AM, Varma S, Cowdell JC. McKenna AL, et al. Among authors: kase am. Qual Manag Health Care. 2024 Jan-Mar 01;33(1):52-58. doi: 10.1097/QMH.0000000000000412. Epub 2023 Jun 2. Qual Manag Health Care. 2024. PMID: 37296511
43 results